Anti-Onchocerca activity and phytochemical analysis of an essential oil from Cyperus articulatus L
© Metuge et al.; licensee BioMed Central Ltd. 2014
Received: 26 December 2013
Accepted: 30 June 2014
Published: 7 July 2014
The lack of a safe and effective adult worm drug and the emergence of resistant animal parasite strains to the only recommended drug, the microfilaricide, ivermectin put many at risk of the devastating effects of the onchocerciasis. The present study was undertaken to investigate the acclaimed anti-Onchocerca activity of the roots/rhizomes of Cyperus articulatus in the traditional treatment of onchocerciasis in North Western Cameroon and to assess the plant as a new source of potential filaricidal lead compounds.
Crude extracts were prepared from the dried plant parts using hexane, methylene chloride and methanol. The antifilarial activity was evaluated in vitro on microfilariae (Mfs) and adult worms of the bovine derived Onchocerca ochengi, a close relative of Onchocerca volvulus. The viabilities of microfilariae and adult male worms were determined based on motility reduction, while for the adult female worms the viability was based on the standard MTT/formazan assay. Cytotoxicity of the active extract was assessed on monkey kidney epithelial cells in vitro and the selectivity indices (SI) were determined. Acute toxicity of the promising extract was investigated in mice. Chemical composition of the active extract was unraveled by GC/MS analysis.
Only the hexane extract, an essential oil exhibited anti-Onchocerca activity. The oil killed both the microfilariae and adult worms of O. ochengi in a dose manner dependently, with IC50s of 23.4 μg/ml on the Mfs, 23.4 μg/ml on adult male worms and 31.25 μg/ml on the adult female worms. Selectivity indices were 4, 4, and 2.99 for Mfs, adult males and adult females, respectively. At a single limit dose of 2000 mg/kg body weight, none of 6 mice that received the essential oil by gavage died. GC/MS analysis revealed the presence of terpenoids, hydrocarbons and fatty acids or fatty acid derivatives as components of the oil.
The essential oil from the roots/rhizomes of Cyperus articulatus is active against O. ochengi microfilariae and adult worms in vitro in a dose dependent manner, hence may provide a source of new anti-filarial compounds. The results also support the traditional use of C. articulatus in the treatment of human onchocerciasis.
KeywordsEssential oil Human onchocerciasis Cyperus articulatus Phytochemical analysis
Onchocerciasis or river blindness is the second leading infectious cause of blindness in humans. According to the World Health Organization, an estimated 37 million people are infected with the parasite and about 300,000 are blind from onchocerciasis . Ivermectin was shown to be both safe and effective in the treatment of onchocerciasis and has become the drug of choice for control by mass drug administration (MDA) strategy . However, ivermectin is only effective against the microfilarial stage (Mfs) of the parasite and prolonged annual ivermectin therapy of at least 10 to 15 years has been predicted to be required for clearance of onchocerciasis from a human population . This makes the search for a drug that kills the adult worm (a cure) a research priority area. During mass treatment of onchocerciasis with ivermectin in forested zones of Central Africa, several adverse events, including encephalopathy and deaths were reported in patients co-infected with L. loa. The potential development of ivermectin-resistant strains of the parasite also demands the identification of alternative drug candidates for onchocerciasis control .
A new chemotherapeutic approach to onchocerciasis uses antibiotics against the essential Wolbachia endobacteria present in many filariae. Doxycycline has been shown to exhibit a macrofilaricidal effect on O. volvulus after a daily dosage for six weeks . Although a report on community-directed delivery of doxycycline for the treatment of onchocerciasis in Cameroon indicated that delivery and compliance are achievable for six weeks , it must be recognized that there are restrictions on the use of this antibiotic on pregnant women, lactating mothers and children less than 9 years of age .
It has been suggested that natural plant products may provide a good alternative source of antifilarial medicines because they are cheap, readily available, have negligible side effects [9, 10] and compliance rate may be high since they are indigenous medicines. Natural products have shown great potentials in treating infectious diseases in humans . Studies on the chemical composition and biological activity of Cyperus articulatus suggest that rhizomes of the plant have anti-plasmodial, antibacterial, anti-fungal, as well as anti-convulsant actions [12–15]. However, the anti-onchocercal activity of C. articulatus has not been evaluated. It is against this backdrop that this study was aimed at evaluating the antifilarial activity of the roots and rhizomes of Cyperus articulatus, a plant used in the traditional treatment of onchocerciasis in North Western Cameroon. In its local use, the roots and rhizomes of the plant are chopped, dried, boiled in water and taken as a decoction. The activity was evaluated on the Mfs and adult worms of Onchocerca ochengi, the closest relative of O. volvulus and best model for anti-O. volvulus drug screens .
Collection and identification of plant
The roots and rhizomes of Cyperus articulatus were collected from inland valleys at Sehn village, Ndu Sub-Division in the North West Region of Cameroon in February 2012, based on ethnopharmacological information. The local name of the plant is “Ndfu”. The voucher specimen was deposited at the National Herbarium in Yaoundé and assigned voucher number 19450/SRF-CAM.
Preparation of plant extracts
The roots along with the rhizomes of Cyperus articulatus were air-dried for three weeks and ground to fine powder. The powder was weighed and macerated for 48 hours, three times per solvent and sequentially in hexane, methylene chloride and methanol, following increasing solvent polarity. The mixture was filtered and the filtrate concentrated under reduced pressure using a rotary evaporator (BUCHI Rotavapor R-200, Switzerland) set at 150 mbar. The hexane and methanol extracts were concentrated under reduced pressure at 45°C while the methylene chloride extract was concentrated at 50°C without the pressure reduction. Residual solvent was removed by drying in air at room temperature (23 - 25°C) for 6 days. The extracts were weighed and stored at −20°C until used.
Isolation of O. ochengi adult worms
The isolation of O. ochengi adult worms was done as described previously . The duration from the slaughtering of a cow to the harvesting of parasites from the skin was always less than 2 hours to ensure full parasite viability. Briefly, fresh pieces of umbilical cattle skin with palpable nodules bought from local slaughterhouses were washed, drained and sterilized with 70% ethanol. O. ochengi adult worms were carefully scraped out of the nodules as single masses and temporarily submerged in 1 mL complete culture medium, CCM [RPMI-1640 (SIGMA, USA) supplemented with 25 mM HEPES, 2 g/L sodium bicarbonate, 2 mM L-glutamine, 5% new born calf serum (SIGMA, USA), 150 units/mL penicillin, 150 μg/mL streptomycin and 0.5 μg/mL amphotericin B (SIGMA, USA), pH 7.4)] using 24-well plates. The adult worms were allowed in the culture medium overnight in a CO2 incubator, during which period the male worms migrated out of the nodular masses. Only wells containing viable worms received treatment with the plant extract. Worms from putrefied nodules were discarded. The viability of worms retained for the assay was ascertained by visual and microscopic examination of adult worm and microfilarial motility using an inverted microscope.
Isolation of O. ochengi microfilariae
The cattle skin was obtained as described for adult worms. About 5 skin snips were obtained from different locations of the skin and incubated separately in small amounts of CCM for 30 minutes. Emerged Mfs were qualified and quantified for O. ochengi species with the aid of an inverted microscope. A selected piece of skin, rich in O. ochengi Mfs was carefully shaved with a razor blade and rinsed with distilled water. It was dabbed with a clean tea cloth to eliminate excess moisture and covered entirely with 70% ethanol. The latter was allowed to evaporate completely in a horizontal flow sterile hood. The ethanol treatment was repeated once. The sterilized skin was tautly attached onto an autoclaved, cylindrical piece of wood using autoclaved thumb nails and close (about 1 mm apart) criss-cross cuts were made into the epidermis and dermis. The assembly was incubated in the culture medium for 4–6 hours. The emerged and highly motile O. ochengi microfilariae were concentrated by centrifugation at 400 × g for 10 minutes and then quantified.
Preparation of mammalian cells
Monkey kidney epithelial cells (LLC-MK2) (ATCC, USA) were cultured at 37°C in humidified air with 5% CO2 in a HeraCell-150 incubator (Thermo Electron, Germany) until the cell layer was almost confluent. The cells were rinsed with a solution of 0.125% trypsin and 0.5 mM EDTA in medium 199 (Sigma, USA) and kept in the same mixture for less than 1 hour for them to be dislodged. The cell suspension was centrifuged at 560 × g for 10 minutes, the supernatant discarded and the pellet re-suspended to 2 × 105 cells/ml in CCM. The cell suspension was dispensed into 96-well microtitre plates (200 μl/well) and kept in the incubator for 3–5 days for cells to grow and become fully confluent. These cells served as feeder layer for the Mfs assays and were also used for cytotoxicity studies.
Preparation of stock solutions of plant extracts
Twenty-five milligrams (25 mg) of each crude extract was weighed and dissolved in microtubes containing 1 mL of 99.9% pure dimethyl sulfoxide (DMSO) (SIGMA, USA) to obtain stock solutions of 25 mg/mL. Complete dissolution was achieved by vortexing. The solutions were stored at 4°C for a maximum of one week before they were used in the assays or were stored frozen at −20°C in convenient aliquots prior to use.
Anti-filarial screening of plant extracts
Primary screens on adult worms
This was done to eliminate inactive extracts. Adult worm assays were conducted in 24-well plates (NUNC, USA) at 37°C in humidified air containing 5% CO2 for 5 days (120 hours) without change of medium. Nodular worm masses (each generally containing a few males and a female worm) were first put in the wells (with 1 ml CCM at the time of worm isolation) without drug. One (1) ml of CCM containing 1 mg/ml of extract was then added into each of quadruplicate wells to give a single final concentration of 500 μg/ml. Four nodular worm masses each, were used in the negative control (2% DMSO in CCM only) and in the positive control (10 μM NYBC01, a gold conjugated compound) wells in which each well also received only one nodular worm mass. After 5 days incubation, adult male worm viability was assessed based on motility scores using an inverted microscope. Motility score was on a scale of 4 (vigorous or normal movement of whole worm, corresponding to 0% inhibition of worm motility), 3 (near normal movement of whole worm or 25% inhibition of worm motility), 2 (whole body of worm motile but sluggish i.e. 50% inhibition of worm motility), 1 (only head or tail of worm moving i.e. 75% inhibition of worm motility), 0 (completely immotile worm i.e. 100% inhibition of worm motility). An extract was considered active on the adult male worm if there was a 100% inhibition of motility; or moderately active for a motility inhibition of 50 - 99%; and inactive if the inhibition was less than 50%.
Adult female worm viability was assessed by the MTT/formazan assay  in which each nodular worm mass was placed in a well of a 48-well microtitre plate containing 500 μl/well of 0.5 mg/ml MTT (Sigma, USA) in incomplete RPMI culture medium, and then incubated in the dark at 37°C for 30 minutes. Adult female worm viability was taken as mean % inhibition of formazan formation relative to negative control at 120 h post addition of plant extract. An extract was considered active on the adult female worm if there was a 90 % or greater inhibition of formazan formation compared to the negative controls; or moderately active if the inhibition was 50 - 89%. It was considered inactive if the inhibition was less than 50%. Adult worm death positively correlates with inhibition of formazan formation.
Primary screen on microfilariae
The extracts were also tested on Mfs at a single concentration of 500 μg/ml, in duplicate wells. The Mfs assay was conducted in 96-well microtitre plates (15 mfs in 200 μl CCM per well) at 37°C in humidified air containing 5% CO2 for 5 days without any change of medium. Fully confluent monkey kidney epithelial cells, serving as feeder layer, were co-cultured with the Mfs. The medium used in preparing the feeder cell layer was removed by a swift decantation before fresh CCM containing plant extract (100 μl) and worms (100 μl) were immediately added. Ivermectin (20 μg/mL) and 2% DMSO served as the positive and negative controls respectively. Mfs motility reduction (viability reduction) were done on a scale of 100% (immotile), through 75% (only tail or head shaking occasionally), through 50% (whole body motile, but sluggishly or with difficulties), to 25% (almost vigorous) to 0% (fully vigorous motility). Scores were made every 24 h, terminating at 120 h using an inverted microscope. Any culture with microbial contamination was not considered. Mfs viability was taken as the mean % reduction at 120 h (day 5) after addition of drug. An extract was considered active if there was a 100% reduction in mfs motility; or moderately active for a motility reduction of 50 - 99%; and inactive if the reduction was less than 50%.
Secondary screens on microfilariae and adult worms
This was done to confirm the activity of active extracts and to determine their IC50, IC100 and selectivity index (SI) values. The extracts were retested as described under primary screens at serial dilutions from 500 to 7.81 μg/ml. All assays were repeated at least thrice and the results obtained are the mean values at each concentration. The graphical analyses and IC50 values were determined using GraphPad Prism software (version 6).
Acute toxicity test
This test was conducted in accordance with the Organisation for Economic Co-operation and Development (OECD) Guidelines for the Testing of Chemicals . Briefly, six (6) nulliparous and non-pregnant female Balb/c mice, about 10 weeks old (averagely 20 g each) were kept in their cages for 5 days prior to dosing to allow for acclimatization to the animal house conditions. Food, but not water was withheld for 4 hours after which, the animals were weighed and the extract was administered orally by gavage at a limit dose of 2000 mg/kg body weight in a volume of 1 ml/100 g of body weight of mouse. The oil (active hexane extract) was dissolved in 100% hybrimax™ DMSO (SIGMA USA) and diluted with sterile distilled water to give 2% DMSO solution. For negative control, six female mice were similarly dosed with 2% DMSO diluted in sterile distilled water. After the test substance was administered, food was withheld for a further 2 hours. The animals were observed individually after dosing, once every 30 minutes during the first 4 hours, and daily thereafter for a total of 14 days. The animals were weighed every two days and observed for physical activity and behavior pattern, food and water intake, changes in skin and fur, eyes and mucous membranes, tremors, convulsions, diarrhea, salivation, lethargy, sleep, coma and death.
Gas chromatography–mass spectrometry (GC/MS) analysis
The essential oil was subjected to GC-MS analysis for phytochemical studies. The GC/MS spectrometer (Agilent 6890/Hewlett-Packard 5975) was fitted with electron ionization (EI) module. Helium was used as the carrier gas at a flow rate of 1 ml/min. The temperature was programmed at 80°C for 5 min then increased to 300°C at the rate of 15°C/min. The temperatures of the injector and EI detector (70 eV) were 280°C and 300°C, respectively. Then 29 μl of the essential oil were injected into the fully calibrated GC/MS spectrometer. The compound identification was based on the comparison of the retention indices (determined relative to the retention times of series of n-alkanes), using an online natural products library.
Preparation of plant extracts
Yield of extracts of roots/rhizomes of C. articulatus using solvents of increasing polarity
Name of plant
Plant part used
Mass of dry powder or residue (approx.)/g
Mass of extract/g
% Recovery of extract
Activity of extracts of roots/rhizomes C. articulatus in primary screens
Effect of extracts from roots/rhizomes of C. articulatus on O. ochengi in primary screens
Test substance (concentration tested)
% Microfilarial motility reduction
% Adult male worm motility reduction
% Adult female worm death
CARhex (500 μg/ml)
Macro- and microfilaricidal
CARmc (500 μg/ml)
CARmet (500 μg/ml)
Inactive on Mfs and adult females; moderately active on adult males
Ivermectin (10 μg/ml)
NYBC01 (10 μM)
Macro- and microfilaricidal
Activity of the essential oil in secondary screens and cytotoxicity test
IC 50 , IC 100 and Selectivity Indices (SI) of the essential oil on O. ochengi
Adult male worm
Adult female worm
Monkey kidney cells (LLC-MK2)
SI = IC50 MKC/IC50 worm
Acute oral toxicity test of the essential oil in mice
GC/MS analysis of the essential oil
Chemical composition of essential oil (hexane extract) from roots/rhizomes of C. Articulatus
Compound (Chemical name)
Retention time (RT) min
Nature of compound
Bicyclo[3.1.1 ]heptan-3-ol, 6,6-dimethyl-2-methylene-, [1S-(1 à,3à,5à)]-
Bicyclo[3.1.1 ]hept-3-en-2-ol, 4,6,6-trimethyl-, [1S-(1 à,2a,5à)]-
Bicyclo[3.1.0]hexan-3-ol, 4-methylene-1-(1-methylethyl)-, [1.S-(1 à,3a,5à)]-
Bicyclo[3.1.1 ]hept-3-en-2-one, 4,6,6-trimethyl-,(1S)-
Naphthalene, 1,2,3,4,4a,5,6,8a-octahydro-7 -methyl-4-methylene-1-(1-methylethyl)-, (1à,4aà,8aà)-
Naphthalene, 1,2,3,4-tetrahydro-1 ,6-dimethyl-4-(1-methylethyl)-, (1S-cis)-
2,3,4-Trifluorobenzoic acid, 4-nitrophenyl ester
2-Naphthalenemethanol, 1,2,3,4,4a ,8a-hexahydro-à, à,4a, 8-tetramethyl-, [2R-(2à,4aà,8aà)]-
3-lsopropyl-6, 7-dimethyltricycio[188.8.131.52(2,8)]decane-9, 1O-diol
Compound (Chemical name)
Retention time (RT) min
Nature of compound
2,2,7,7 -Tetramethyltricyclo[184.108.40.206(1 ,6)]undec-4-en-3-one
Acetic acid, 3-hyd roxy-6-isopropenyl-4, 8a-dimethyl-1 ,2,3,5,6,7,8, 8aoctahydronaphthalen-2-yl ester
5( 1H)-Azulenone, 2,4,6,7,8, 8a-hexahydro-3, 8-dimethyl-4-( 1-methylethylidene)-, (8S-cis)-
Perhydrocyclopropa[e]azulene-4,5,6-triol, 1,1 ,4,6-tetramethyl
1 H-Cycloprop[e]azulen-7 -01, decahydro-1 ,1,7 -trimethyl-4-methylene-, [1ar-(1 aà,4aà,7a,7aa,7bà)]-
Spiro[4.5]decan-7 -one, 1,8-dimethyl-8,9-epoxy-4-isopropyl-
2( 1H) Naphthalenone, 3,5,6,7,8, 8a-hexahyd ro-4, 8adimethyl-6-( 1-methylethenyl)-
2( 1H)-Naphthalenone, 4a,5,6, 7, 8,8a-hexahydro-6-[1-(hydroxymethyl)ethenyl]-4,8adimethyl-, [4ar-(4aà,6à,8aà)]-
1-Naphthalenol, decahydro-1 ,4a-dimethyl-7 -( 1-methylethylidene )-, [1 R-( 1à,4aa,8aà)]-
Compound (Chemical name)
Retention time (RT) min
Nature of compound
2,6-Dimethyl-1 ,3,5,7-octatetraene, E, E-
1 H-Cycloprop[e]azulene, 1a,2,3,4,4a,5,6, 7boctahydro-1 ,1,4,7 -tetramethyl-, [1aR-(1aà,4à,4aa, 7bà)]-
3H-3a, 7-Methanoazulene, 2,4,5,6,7 ,8-hexahydro-1,4,9,9-tetramethyl-, [3aR-(3aà,4a,7à)]-
Benzene, 1-(1 ,5-dimethyl-4-hexenyl)-4-methyl-
Benzene, 1-methyl-4-(1 ,2,2-trimethylcyclopentyl)-,(R)-
Azulene, 1,2,3,5,6,7 ,8,8a-octahydro-1 ,4-dimethyl-7-(1-methylethenyl)-, [1 S-(1 à,7à,8aa)]-
9, 12-0ctadecadienoic acid (Z, Z)-
9,12, 15-0ctadecatrienoic acid, (Z, Z, Z)-
Isophthalic acid, di(2-methylprop-2-en-1-yl) ester
Trichloroacetic acid, hexadecyl ester
Oodecanoic acid, dodecyl ester
Oodecanoic acid, tetradecyl ester
Oodecanoic acid, hexadecyl ester
The present study was carried out to investigate the acclaimed antifilarial activity of roots and rhizomes of Cyperus articulatus in the traditional treatment of onchocerciasis in North Western Cameroon and to assess the potential of the plant as a new source of novel O. volvulus filaricidal lead compounds. Solvents of increasing polarity (hexane, methylene chloride and methanol) were sequentially used to produce three crude extracts from the roots/rhizomes of C. articulatus. The hexane extract (an essential oil) was the most active, showing activity against microfilariae and adult worms in a dose dependent manner. The oil was apparently more active against adult males (IC50 = 23.4 μg/ml) than adult females (IC50 = 31.25 μg/ml) (Table 3), probably because motility reduction (used in assessing the males) is different from biochemical death (used in assessing the females).
This activity shows that the roots/rhizomes contain anti-Onchocerca principles and justifies their use in the traditional treatment of human onchocerciasis in the area. Thus, a search for novel filaricides from the plant materials should be focused on the non-polar extract. This is in contrast to the practice by herbalists who use the polar solvent, water in preparing the decoctions, indicating that their extraction procedure may be grossly inefficient . The use of oils in extraction (assuming compounds remain stable) or addition of edible oils in preparation of the decoction may improve on yield and overall efficacy in the traditional medicine practice. Most herbalists around the world rely heavily on use of the universally available and safe solvent, water in the preparation of medicinal decoctions. This is one important limitation of traditional medicine – irrationality, leading also to frequent lack of standardization in the medicines. Thus, it may not be surprising that despite the widespread use of traditional medicine in developing countries, Neglected Tropical Diseases like onchocerciasis continue to increase in prevalence and intensity in some areas. On the other hand, there exist many substances that show activity in vivo without being active in vitro. Such substances may be extractable using the aqueous solvents.
Phytochemical analysis of the essential oil showed that it contained a wide range of secondary metabolites: monoterpenes, sesquiterpenes, hydrocarbons, fatty acids and fatty acid derivatives (Table 4). Although the anti-onchocercal activity of the essential oil cannot be ascribed at this point to any of the compounds, a review by Kuete and Efferth  indicated that terpenoids from Cameroonian plants showed best activities as anti-parasitic agents. Nyasse and his group  also identified sesquiterpenes from C. articulatus collected from Cameroon. Extracts from plants may provide a natural combination of biologically active compounds responsible for the death of the parasite. The different compounds in the extract may be working in synergy to kill the parasite by providing an arsenal to multiple drug targets. For example, the present essential oil contains corymbolone (a sesquiterpene) and spathulenol which have been shown to exhibit anti-plasmodial  and antifungal [23, 24], activities, respectively. Further studies are required to narrow down to the antifilarial principles in the essential oil. Although single pure compounds may inhibit particular molecular targets and even kill the parasite, they may be more susceptible to parasite resistance than an extract with possibly many active compounds. A number of other extracts from medicinal plants used in Cameroon have also been shown to exhibit anti-Onchocerca activity [25, 26].
Although the essential oil from C. articulatus was moderately cytotoxic on monkey kidney cells, in the acute toxicity studies none of six mice died at the limit dose of 2000 mg/kg body weight, and only one was traumatized, probably by the drug administration procedure. This safety profile may imply a detoxification mechanism in the liver or kidneys in vivo. The finding in mice also lends credence to the ethnopharmacologically observed lack of toxicity or adverse effects in humans, at least in the short term.
The essential oil from the roots/rhizomes of C. articulatus is active against O. ochengi microfilariae and adult worms, hence may provide a source of new anti-filarial lead compounds. The results obtained also support the use of C. articulatus in traditional medicine for the treatment of human onchocerciasis.
Complete culture medium
Organization for economic co-operation and development
Hexane extract of the root/rhizomes of Cyperus articulatus.
This investigation received financial assistance from the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) (Project A70107). The authors are grateful to Evans Mainsah (University of Buea) and Pastor Denis Bughe of Sehn village, North West Cameroon, for the provision of ethnopharmacological information and collection of the plant investigated.
- World Health Organization: Action Plan 2006 – 2011. Global Initiative for the Elimination of Avoidable Blindness. 2007, WHO, 29-[http://www.who.int/blindness/Vision2020_report.pdf]Google Scholar
- World Health Organization: Document WHO/PBL/91.24. Strategies for Ivermectin Distribution through Primary Health Care Systems. 1991, Geneva: WHOGoogle Scholar
- Richards FO, Miri E, Meredith S, Guderian R, Sauerbrey M, Remme H, Packard R, Ndiaye JM: Onchocerciasis. Bull World Health Organ. 1998, 76 (Suppl. 2): 147-149.PubMedPubMed CentralGoogle Scholar
- Gardon J, Gardon-Wendel M, Demanga N, Kamgno J, Chippaux J, Boussinesq M: Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet. 1997, 350: 18-22. 10.1016/S0140-6736(96)11094-1.View ArticlePubMedGoogle Scholar
- Lizotte-Waniewski M, Tawe W, Guiliano D, Lu W, Williams SA, Lustigman S: Identification of potential vaccine and drug target candidates by expressed sequence tag analysis and immunoscreening of O. volvulus larval cDNA libraries. Infect Immun. 2000, 68 (6): 3491-3501. 10.1128/IAI.68.6.3491-3501.2000.View ArticlePubMedPubMed CentralGoogle Scholar
- Hoerauf A: Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis. Curr Opin Infect Dis. 2008, 21: 673-681. 10.1097/QCO.0b013e328315cde7.View ArticlePubMedGoogle Scholar
- Wanji S, Tendongfor N, Theolbal N, Esum M, Che J, Nkaescheu A, Alassa F, Kamnang G, Enyong P, Taylor M, Hoerauf A, Taylor D: Community-directed delivery of doxycycline for the treatment of onchocerciasis in Cameroon in areas of co-endemicity with loiasis in Cameroon. Parasit Vectors. 2009, 2: 39-10.1186/1756-3305-2-39.View ArticlePubMedPubMed CentralGoogle Scholar
- Stingl P: Onchocerciasis: developments in diagnosis, treatment and control. Int J Dermatol. 2009, 48: 393-396. 10.1111/j.1365-4632.2009.03843.x.View ArticlePubMedGoogle Scholar
- Ebigwai JK, Ilondu EM, Markson AA, Ekeleme E: In vitro evaluation of the essential oil extract of six plant species and ivermectin on the microfilaria larva of Simulium yahense. Res J Med Plant. 2012, 6: 461-465. 10.3923/rjmp.2012.461.465.View ArticleGoogle Scholar
- Comley JCW: New macrofilaricidal leads from plants. Trop J Parasitol. 1990, 59 (1): 77-83.Google Scholar
- Oliver-Bever B: Medicinal Plants in Tropical West Africa. 1986, London: Cambridge University Press, 123-169.View ArticleGoogle Scholar
- Rukunga GM, Muregi FW, Omar SA, Gathirwa JW, Muthaura CN, Peter MG, Heydenreich M, Mungai GM: Anti-plasmodial activity of the extracts and two sesquiterpenes from Cyperus articulatus. Fitoterapia. 2008, 79 (3): 188-190. 10.1016/j.fitote.2007.11.010.View ArticlePubMedGoogle Scholar
- Oladusu LA, Usman LA, Olawore NO, Atata RF: Antibacterial activity of rhizomes essential oils from two types of Cyperus articulatus growing in Nigeria. Adv Biol Res. 2011, 5 (3): 179-183.Google Scholar
- Mongelli E, Desmarchelier C, Coussio J, Ciccia G: Antimicrobial activity and interaction with DNA of medicinal plants from the Peruvian Amazon region. Rev Argent Microbiol. 1995, 27 (4): 199-203.PubMedGoogle Scholar
- Bum NE, Schmutz M, Meyer C, Rakotonirina A, Bopelet M, Portet C, Jeker A, Rakotonirina SV, Olpe HR, Herrling P: Anticonvulsant properties of the methanolic extract of Cyperus articulatus (Cyperaceae). J Ethnopharmacol. 2001, 76 (2): 145-150. 10.1016/S0378-8741(01)00192-1.View ArticlePubMedGoogle Scholar
- Trees AJ, Graham SP, Renz A, Bianco AE, Tanya V: Onchocerca ochengi infections in cattle as a model for human onchocerciasis: Recent developments. Parasitolology. 2000, 120: 5133-5142.View ArticleGoogle Scholar
- Cho-Ngwa F, Daggfeldt A, Titanji VPK, Gronvik K: Preparation and characterization of specific monoclonal antibodies for the detection of adult worm infections in onchocerciasis. Hybridoma. 2005, 24 (6): 283-290. 10.1089/hyb.2005.24.283.View ArticlePubMedGoogle Scholar
- Comley JCW, Townson S, Rees MJ, Dobinson A: The further application of MTT-formazan colorimetry to studies on filarial viability. Trop Med Parasitol. 1989, 40: 311-316.PubMedGoogle Scholar
- Organization for Economic Co-operation and Development (OECD): Guidelines for the Testing of Chemicals. 2001, Paris, Monograph No 423Google Scholar
- Gupta A, Naraniwal M, Kothari V: Modern extraction methods for the preparation of plant extracts. Int J Appl Nat Sci. 2012, 1 (1): 8-26.Google Scholar
- Kuete V, Efferth T: Cameroonian medicinal plants: pharmacology and derived natural products. Front Pharmacol. 2010, 1: 123-View ArticlePubMedPubMed CentralGoogle Scholar
- Nyasse B, Tih RG, Sodengam BL, Martins MT, Bodo R: Mandassindione and other sesquiterpenic ketones from Cyperus articulatus. Phytochemistry. 1988, 27: 3319-3321. 10.1016/0031-9422(88)80055-4.View ArticleGoogle Scholar
- Al-Ja’fari AH, Vila R, Freixa B, Tomi F, Casanova J, Costa J, Caniqueral S: Composition and antifungal activity of the essential oil from the rhizome and roots of Ferula hermonis. Phytochemistry. 2011, 74 (11–12): 1406-1413.View ArticleGoogle Scholar
- Waikedre J, Vitturo CI, Molina A, Theodoro PN, Do Rosário Rodrigues Silva M, Espindola LS, Maciuk A, Fournet A: Antifungal activity of the essential oils of Callitris neocaledonica and C. sulcata heartwood (Cupressaceae). Chem Biodivers. 2012, 9 (3): 644-653. 10.1002/cbdv.201100229.View ArticlePubMedGoogle Scholar
- Titanji VPK, Evehe MS, Ayafor JF, Kimbu SF: Novel Onchocerca volvulus filaricides from Carapa procera, Ployalthia suaveolens and Pachypodanthium staudtii. Acta Leiden. 1990, 59: 377-382.PubMedGoogle Scholar
- Cho-Ngwa F, Abongwa M, Ngemenya NM, Nyongbela KD: Selective activity of extracts of Margaritaria discoidea and Homalium africanum on Onchocerca ochengi. BMC Complement Altern Med. 2010, 10: 62-10.1186/1472-6882-10-62.View ArticlePubMedPubMed CentralGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/14/223/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.